Outrageous prices of orphan drugs: a call for collaborationLucio Luzzatto, Hanna I. Hyry, Arrigo Schieppati et al.|The Lancet|2018Cited by 160
The impact of FDA and EMA regulatory decision-making process on the access to CFTR modulators for the treatment of cystic fibrosisEnrico Costa, Marco Cipolli, Silvia Girotti et al.|Orphanet Journal of Rare Diseases|2022Cited by 51
Efficacy and acceptability of antidepressants on the continuum of depressive experiences in patients with cancer: Systematic review and meta-analysisGiovanni Ostuzzi, Corrado Barbui, Laura Benda et al.|Cancer Treatment Reviews|2015Cited by 45
Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (<scp>HASTE</scp>): How to meet major health needs at a reasonable costEnrico Costa, Lucio Luzzatto, Prosper Tibalinda et al.|American Journal of Hematology|2020Cited by 31
Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injuryLucia De Franceschi, Oliviero Olivieri, Enrico Costa et al.|European Journal of Internal Medicine|2020Cited by 22